Food and Drugs Monitoring Agency Bans Diethylene Glycol

By Editorial Team 17/10/2022
Summary

The Food and Drug Monitoring Agency (BPOM) has prohibited pharmaceutical companies from registering products containing diethylene glycol (DEG) and ethylene glycol (EG). BPOM head Penny K. Lukito explained the ban is necessary due to rising cases of acute kidney failure allegedly caused by the consumption of syrup drugs containing both substances. "All syrup-based drug products for children and adults are not allowed to use DEG and EG," she said on Saturday.

The ban is a response to the World Health Organization's (WHO) report on Oct 5, stating that syrup-based medicines for children containing DEG and EG were among the causes of acute kidney failures in Gambia, Africa. These syrup-based drugs are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup, made by Maiden Pharmaceuticals Limited, India. Based on BPOM's investigation, these products are not registered in Indonesia. "However, BPOM is investigating the possible content of DEG and EG in other materials used as additional solvents," Penny said.

Register now and get free access.

If you want to get free access to our Daily Insights and Weekly Digest, please click "Sign up" button below. If you already have an account, please login.

Sign up
Log in
What do subscribers receive?

As a subscriber, you'll receive daily insights, weekly business digests, and quarterly industrial reports.

What kind of pieces will i get?

In-depth reports on assumption and impact analysis, as well as update and trends mapping, written by our credible and experienced analysts.

And, there is something else…

Register now and get free access, click here to register. Feel free to contact us with any additional questions you have.